Plasma prednisolone concentrations and kinetics in renal transplant patients. 1983

W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple

Plasma prednisolone concentrations were measured in 26 renal transplant (RT) patients and five control subjects. A linear relationship was found between prednisolone dosage in mg/kg and area under the plasma concentration time curve in seven stable RT patients (r = 0.98) and in all subjects (n = 19) with estimated prednisolone clearance rates (CLp) between 0.075 and 0.11 L/kg/hr (r = 0.96). The greatest deviation from this occurred in five patients having reduced CLp with prolonged prednisolone half life (t1/2p) and in one having increased CLp while taking phenytoin. Three of the five with reduced clearance had steroid induced diabetes and one a Cushingoid appearance. There was some correlation between peak plasma prednisolone and dosage (r = 0.77) in all subjects, but none between creatinine clearance and t1/2p or CLp.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
June 1979, British medical journal,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
January 1981, The Ulster medical journal,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
December 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
April 1982, Kidney international,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
August 1985, British journal of clinical pharmacology,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
June 1977, The New England journal of medicine,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
January 1988, European journal of clinical pharmacology,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
December 2019, Therapeutic drug monitoring,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
January 1981, European journal of clinical pharmacology,
W E Nelson, and C C Doherty, and J F Douglas, and M G McGeown, and H Delargy, and D J Temple
September 2006, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!